登录新浪财经APP 搜索【信披】查看更多考评等级 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： 1、泰豪科技股份有限公司（以下简称"公司"）于2025年4月3日召开第九届董事会第三次会议和第九届 监事会第三次会议审议通过了《关于公司发行股份购买资产暨关联交易方案的议案》《关于〈泰豪科技 股份有限公司发行股份购买资产暨关联交易预案〉及其摘要的议案》等相关议案。 2、自本次交易预案披露以来，公司及交易相关方积极推进相关工作。截至本公告披露日，由于本次交 易所涉及的审计、评估工作尚未完成。因此，公司预计无法在首次董事会决议公告日后的6个月内发出 召开审议本次交易相关事项的股东会通知。根据《上海证券交易所上市公司自律监管指引第6号一一重 大资产重组》的相关规定，经交易各方协商，将继续推进本次交易事项。 2025年5月7日、2025年6月7日、2025年7月5日、2025年8月5日、2025年9月4日，公司分别披露了《关于 发行股份购买资产暨关联交易事项的进展公告》（公告编号：临2025-036、042、045、056 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 日前，南新制药（688189）公告，公司近日收到中国证监会出具的《立案告知书》，因公司涉嫌年报信息披露违法违规，证监会决定对公司立案。立案调 查期间，公司将积极配合中国证监会的调查工作，并严格按照相关法律法规及监管要求及时履行信息披露义务。 同日，南新制药公告称终止筹划重大资产重组事项。据南新制药公告，公司于2025年8月27日披露了《关于筹划重大资产重组暨签署<收购意向协议>的提 示性公告》，公司与西藏未来生物医药股份有限公司、许昌未来制药有限责任公司和合肥市未来药物开发有限公司（合称"未来医药"）签署了《收购意向 协议》，公司拟以现金方式收购未来医药持有的标的资产组。根据初步研究和测算，此次交易预计构成重大资产重组情形。 今年8月27日，南新制药披露，拟收购未来医药持有的标的资产组，包括已上市标的品种"多种微量元素注射液（Ⅰ）""多种微量元素注射液（Ⅱ）"和在 研标的品种"多种微量元素注射液（Ⅲ）"以及所有相关所有权和知识产权。此次交易整体作价不超过4.8亿元。 南新制药表示，《收购意向协议》签署后，公司积极组织交易各方推进本次交易。公司与交易对方就本次交 ...

中国经济网北京10月1日讯 索辰科技(688507.SH)9月29日晚间发布重大资产购买报告书(草案)。本 次交易方案为支付现金购买资产的方式。索辰科技拟通过全资子公司数字科技收购马国华、田晓亮、华 宇科创、前海股权、林威汉、王琳、谷永国、中原前海、朗润创新、北京幸福持有的力控科技60%股 权。交易完成后，力控科技将成为上市公司二级控股子公司。 截至评估基准日，力控科技100%股权评估值为32,400.00万元，经交易各方协商，力控科技100%股 权的交易定价确定为32,000.00万元。标的公司控股股东及核心管理团队认同本次交易完成后与上市公司 在核心技术、客户资源、业务协同及管理整合等多方面的协同效应，因此马国华、田晓亮、林威汉、王 琳、谷永国等公司核心管理团队的交易对价对应力控科技100%股权为27,067.25万元。 由于在本次交易前，标的公司部分财务投资人投资估值较高，考虑到不同交易对方初始投资成本及 入股时间等因素，经上市公司与交易各方沟通协商，最终确定前海股权、中原前海交易对价分别为 2,241.37万元、747.12万元，对应力控科技100%股权为50,953.71万元；华宇科创、北京幸福交易 ...

Group 1 - The transaction involves a significant asset sale, issuance of shares, and cash payment for asset acquisition, along with fundraising, all of which are interdependent and form an integral part of a major asset restructuring [2][3][4] - The company plans to sell 100% equity of Sichuan Development Maglev Technology Co., Ltd. and related assets to Sichuan Shudao Rail Transit Group Co., Ltd., and 100% equity of Chengdu Xinzhu Transportation Technology Co., Ltd. to Sichuan Road and Bridge Construction Group Co., Ltd. [3] - The company intends to issue shares and pay cash to acquire 60% equity of Sichuan Shudao Clean Energy Group Co., Ltd., which will become a controlling subsidiary post-transaction [4] Group 2 - The company aims to raise matching funds by issuing shares to no more than 35 qualified investors, with the total amount not exceeding 100% of the transaction price for the asset acquisition [5] - This transaction is expected to constitute a major asset restructuring and related party transaction but does not qualify as a restructuring listing [6] - The company has disclosed the history of this transaction, including stock suspension and resumption dates, and relevant announcements made on various dates [7][8] Group 3 - As of the announcement date, the audit and evaluation work related to the transaction is still ongoing, and the company will convene a board meeting to review the transaction once these tasks are completed [9]

Group 1 - The core point of the article is that Nanjing Pharmaceutical has been investigated by the China Securities Regulatory Commission (CSRC) for suspected violations of annual report information disclosure laws, leading to the termination of its major asset restructuring plan [2] - Nanjing Pharmaceutical signed an acquisition intention agreement with Future Pharmaceutical on August 26, 2025, which was expected to constitute a major asset restructuring according to relevant regulations [2] - The company has faced continuous revenue decline since its listing in 2020, with a significant loss of 357 million yuan in 2024 and a 71.28% year-on-year revenue drop in the first half of 2025 [3] Group 2 - As of September 30, Nanjing Pharmaceutical's stock price closed at 11.37 yuan per share, with a market capitalization of 3.12 billion yuan [7] - In the first half of 2025, the company reported revenue of 61.8463 million yuan and a net loss of 40.0023 million yuan, with a non-recurring net profit loss of 41.7314 million yuan [3]

南财智讯9月30日电，海汽集团披露重大资产重组进展的公告，公司计划通过支付现金及/或资产方式， 从海南省旅游投资集团有限公司手中收购海南旅投免税品有限公司的控制权。此次交易不涉及发行股份 或募集配套资金。自2024年9月以来，公司多次发布进展公告，因国内免税市场竞争加剧和消费需求放 缓，标的公司业绩不及预期，公司正在与交易各方就交易方案进行反复论证和沟通协商。此次交易存在 多项不确定性，包括交易方案的最终协商、董事会和股东大会的审议，以及其他必要的批准或核准。公 司将根据本次交易相关工作的进展情况，及时履行信息披露义务，继续与交易各方就交易方案进行反复 论证和沟通协商。 ...

海南海汽运输集团股份有限公司公告重大资产重组进展。公司拟通过支付现金及/或资产方式，收购剥 离华庭项目后的海旅免税控制权，不涉及发行股份或配套募资，具体资产范围待协商。原重组方案曾计 划发行股份及募资，2024年9月进行重大调整。自调整以来，公司持续披露进展。受国内免税市场竞争 激烈、消费需求放缓等影响，标的公司业绩不及预期，公司仍在与各方反复论证协商。交易方案需履行 决策和审批程序，最终实施存在重大不确定性，公司将依规及时披露信息。 ...

Group 1 - Ningbo Founder Automotive Mould Co., Ltd. is planning to acquire 60% equity of Junpeng Communication held by Pengxin Chuangzhan in cash [1] - Prior to the transaction, Ningbo Founder already holds 40% equity of Junpeng Communication, and upon completion, Junpeng Communication will become a wholly-owned subsidiary [1] - The transaction is expected to constitute a major asset restructuring and is classified as a related party transaction, without involving share issuance or changes in control [1] Group 2 - The company has disclosed progress multiple times before, and as of the announcement date, it is organizing intermediary institutions to conduct due diligence, auditing, and evaluation [1] - No formal documents have been signed by the relevant parties, and the transaction is still in the planning stage with core elements pending negotiation [1] - There is significant uncertainty regarding the transaction, and the company will fulfill decision-making approval and information disclosure obligations as required [1]

富临精工(300432.SZ)公告，公司、宁德时代新能源科技股份有限公司("宁德时代")拟共同对公司子公司江西升 华新材料有限公司("江西升华")增资扩股，公司拟增资人民币10亿元，宁德时代拟增资人民币25.63亿元。 本 次交易完成后，宁德时代持股比例为51.0000%，公司持股比例为47.4096%。本次交易预计构成重大资产重 组，本次交易筹划事项公司股票不停牌。 关注公众号，点击公众号主页右上角" ··· "，设置星标 "⭐" ，关注 鑫椤锂电 资讯~ 本文来源：和讯财经 会议时间： 2025年11月12-13日（12号报到） 会议地点： 中国·上海 会议咨询： 13248122922(微信同） END 据悉，江西升华经过多年积累和不断迭代，其高压实密度磷酸铁锂产品具备技术性能优势。公司与宁德时代拟 共同对公司子公司江西升华增资扩股，是公司与宁德时代建立全面战略合作关系在股权与资本合作层面的进一 步深入推进，有利于加快推进江西升华在优质磷酸铁锂产品研发与生产、国际化拓展、供应链升级及储能市场 发展等方面进程，提升江西升华的资本实力和综合竞争力。 会议详情： 会议主办： 鑫椤资讯 ...

Core Viewpoint - Bohai Automobile plans to invest 2.728 billion yuan to acquire stakes in four companies, aiming to enhance its core competitiveness amid ongoing operational challenges [1][4]. Group 1: Acquisition Details - The company intends to purchase 51% of Beijing Beiqi Moulding Technology Co., Ltd. and Langfang Andautop Co., Ltd., 100% of Infa Intelligent Technology (Beijing) Co., Ltd., and 50% of Langfang Leni Wiring System Co., Ltd. [1][2] - The total transaction price is expected to be 2.728 billion yuan, with an additional fundraising of up to 1.379 billion yuan from no more than 35 specific investors [1][4]. Group 2: Business Expansion - Following the acquisition, Bohai Automobile will expand its product line to include automotive exterior parts, seat frames, automotive electronic products, and wiring harnesses [1][2]. - The integration of the acquired companies' R&D capabilities is expected to enhance the company's competitiveness in the automotive parts sector [1]. Group 3: Financial Performance - The four target companies have mixed financial performances, with net profits for Beiqi Moulding and Langfang Andautop being 80.39 million yuan and 72.72 million yuan respectively, while Infa Intelligent Technology reported losses [3]. - Bohai Automobile has faced significant financial difficulties, with net losses increasing over the past four years, totaling 1.264 billion yuan in 2024 [4]. - The company's revenue has also been declining, with a 26.46% year-on-year drop in the first half of this year [4]. Group 4: Market Reaction - Following the announcement, Bohai Automobile's stock price surged to 5.10 yuan per share, hitting the daily limit [5].